Presentations

A paradigm shift in clinical trials
Claude Farrugia, EIPG President
EIPG Presentation at European Clinical Trial Day, an international conference organised by AFI and Regione Lombardia, endorsed by EIPG, Milan 2017.   

Introduzione al tema serializzazione e tracciabilità
Claude Farrugia, EIPG President
EIPG Presentation at 57 Simposio AFI, Rimini 2017.

Making the case for personalised medicine
Barbara Freischem
Presentation at EIPG – Scientific Symposium “Precision Medicine: Paradigm Shifts for Millennial Patients”, Malta 2017.

Precision medicines – delivering to patients
Tricia Kennerley
Presentation at EIPG – Scientific Symposium “Precision Medicine: Paradigm Shifts for Millennial Patients”, Malta 2017.

Shortages of medicines originating from manufacturing
Maurizio Battistini, EIPG Vice-President
EIPG Presentation at Pharmaceutical Supply Chains I, a training school organised by Cost Action CA15105: European Medicines Shortages Research Network – addressing supply problems to patients (Medicines Shortages), Lisbon 2017.

Verification of medicinal products in Europe: An EIPG perspective
Claude Farrugia, EIPG Vice-President
EIPG Presentation at VAPI-UPIP Seminar “Implementation of the new Delegated Act on Falsified Medicines”, Limelette 2016.

Formulation of protein based drugs
Claude Farrugia, EIPG Vice-President
EIPG Presentation at the EPSA Autumn Assembly 2015, Malta 2015.

Future supply chains for the pharmaceutical industry – a collaborative approach
Prof Clive Badman OBE
Presentation at EIPG – Royal Pharmaceutical Society Scientific Symposium “Advances in Technology Impacting the Pharmaceutical Industry” at the University of Strathclyde, Glasgow 2015.

CMAC: A national research centre in continuous manufacturing and crystallisation
Prof Alastair Florence
Presentation at EIPG – Royal Pharmaceutical Society Scientific Symposium “Advances in Technology Impacting the Pharmaceutical Industry” at the University of Strathclyde, Glasgow 2015.

New Medicine Evaluation, Scottish Medicines Consortium
Prof Angela Timoney
Presentation at EIPG – Royal Pharmaceutical Society Scientific Symposium “Advances in Technology Impacting the Pharmaceutical Industry” at the University of Strathclyde, Glasgow 2015.

PHAR-IN: Competences for industrial pharmacy practice in biotechnology
Prof Kristien De Paepe
Presentation at EIPG – Royal Pharmaceutical Society Scientific Symposium “Advances in Technology Impacting the Pharmaceutical Industry” at the University of Strathclyde, Glasgow 2015.

Cancer Research UK Formulation Unit
Dr Gavin Halbert
Presentation at EIPG – Royal Pharmaceutical Society Scientific Symposium “Advances in Technology Impacting the Pharmaceutical Industry” at the University of Strathclyde, Glasgow 2015.

A view on drug shortages from EIPG
Claude Farrugia, EIPG Vice-President
EIPG Presentation at VAPI-UPIP Seminar “The Challenge of Drug Shortages”, Brussels 2015.

Development of biopharmaceuticals: structure and formulation considerations
Amon Wafelman, EIPG SIG Production co-chair
EIPG Presentation at the EPSA Autumn Assembly 2014, Hradec Králové 2014.

Pharma 2014: Rework, Renaissance or Ragnarök?
Claude Farrugia, EIPG Vice-President
EIPG Lecture at meeting of Suomen Farmasialiitto, Helsinki 2014.

Industrial Pharmacist Vision of Clinical Trials
Jean Pierre Paccioni, EIPG President
Presentation at EIPG – BIPA Symposium “Clinical Trials Research” at the Faculty of Pharmacy, Medical University of Sofia, Sofia 2014.

Implementation of Annex 13 of the EU GMP Guide
Jacques Morénas, Deputy Director, Inspection Division, ANSM
Presentation at EIPG – BIPA Symposium “Clinical Trials Research” at the Faculty of Pharmacy, Medical University of Sofia, Sofia 2014.

Current Landscape for Safety Reporting in Clinical Trials
Borislav Borissov, Former Head of BDA
Presentation at EIPG – BIPA Symposium “Clinical Trials Research” at the Faculty of Pharmacy, Medical University of Sofia, Sofia 2014.

Regulatory Control of Clinical Trials
Georgina Gal, Regulatory Affairs Manager, AbbVie, Hungary
Presentation at EIPG – BIPA Symposium “Clinical Trials Research” at the Faculty of Pharmacy, Medical University of Sofia, Sofia 2014.

Biotech and Advanced Therapies: A Pharma Renaissance
Claude Farrugia, EIPG Vice-President
Presentation at EIPG – VAPI-UPIP Symposium “Biotech and Advanced Therapies: Challenges and Opportunities” at the Faculty of Medicine and Pharmacy, Campus Jette, Vrije Universiteit van Brussel, Brussels 2013.

Regulatory Perspectives on Biosimilars in Europe
Bruno Flamion, Professor of Physiology and Pharmacology, Molecular Physiology Research Unit, University of Namur
Presentation at EIPG – VAPI-UPIP Symposium “Biotech and Advanced Therapies: Challenges and Opportunities” at the Faculty of Medicine and Pharmacy, Campus Jette, Vrije Universiteit van Brussel, Brussels 2013.

What Medical Biotechnology can Accomplish…
Luc Kupers, Director Science and Communication, Genzyme
Presentation at EIPG – VAPI-UPIP Symposium “Biotech and Advanced Therapies: Challenges and Opportunities” at the Faculty of Medicine and Pharmacy, Campus Jette, Vrije Universiteit van Brussel, Brussels 2013.

Nanobodies®: Journey from Research to Commercial
Hilde Revets, Senior Research Fellow, Ablynx
Presentation at EIPG – VAPI-UPIP Symposium “Biotech and Advanced Therapies: Challenges and Opportunities” at the Faculty of Medicine and Pharmacy, Campus Jette, Vrije Universiteit van Brussel, Brussels 2013.

Pharma-Economical Situation in Belgium
Leo Neels, CEO pharma.be
Presentation at EIPG – VAPI-UPIP Symposium “Biotech and Advanced Therapies: Challenges and Opportunities” at the Faculty of Medicine and Pharmacy, Campus Jette, Vrije Universiteit van Brussel, Brussels 2013.

Biopharmaceuticals
Amon Wafelman, EIPG Netherlands Delegate
Presentation at EIPG General Assembly, Brussels 2013.

The Pharmaceutical Industry and the Industrial Pharmacist: A Partnership for the 21st Century
Claude Farrugia, EIPG Vice-President
EIPG Lecture at the meeting of the Regional Pharmacy Union of Sofia, Sofia 2012.

Introducing Inter-Professional Education into the Undergraduate Pharmacy Syllabus
Jane Nicholson, EIPG Executive Director
Presentation at EAFP Annual Conference 2012, Utrecht University, Utrecht 2012.

The Current State of the Pharmaceutical Industry in Portugal
Heitor Costa, APIFARMA Executive Director
Presentation at EIPG General Assembly, Lisbon 2012.

The implications of implementing the Directive on Falsified Medicines
Claude Farrugia, EIPG Vice-President
Presentation at Symposium at the Faculdade de Farmácia, Universidade de Lisboa, Lisbon 2012.

French pharmaceutical record (DP) and batch recall services
Jean-Pierre Paccioni, EIPG Treasurer
Presentation at Symposium at the Faculdade de Farmácia, Universidade de Lisboa, Lisbon 2012.

Pharmaceutical Industry – The challenges and the opportunities
Gino Martini, EIPG President
Presentation at Symposium at the Faculdade de Farmácia, Universidade de Lisboa, Lisbon 2012.

Challenges of Cold Supply Chain
Armin Hoffman, EIPG German Delegate
Presentation at Symposium at the Faculty of Pharmacy, University of Alcala, Madrid 2011.

Continuing Professional Development (CPD)
José C. Montilla Canís, Presidente de la Comisión Nacional de Farmacia Industrial y Galénica
Presentation at Symposium at the Faculty of Pharmacy, University of Alcala, Madrid 2011.

The Future of the Pharmaceutical Industry in Spain
Vicente Hernández Vázquez
Presentation at Symposium at the Faculty of Pharmacy, University of Alcala, Madrid 2011.

The Pharmacy Profession in the Industrial Environment: Curricula Design
Julio Alvarez-Builla, Dean of the Faculty of Pharmacy, University of Alcala
Presentation at Symposium at the Faculty of Pharmacy, University of Alcala, Madrid 2011.

Challenges and Opportunities for the Pharmaceutical Industry
Gino Martini, EIPG President
Presentation at Symposium at the Faculty of Pharmacy, University of Alcala, Madrid 2011.

Pre-Registration Pharmacist Information Pack
Sponsored by Gino Martini, EIPG President, and David Tainsh, GlaxoSmithKline Pharmaceuticals
A brochure by AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline Pharmaceuticals and MSD on pre-registration pharmacist training (Version 3.2).

Development Challenges Facing Big Pharma And The Industrial Pharmacist
Gino Martini, EIPG President
Presentation at Malta Qualified Persons Association-European Industrial Pharmacists Group-University of Malta joint seminar “The Successes And Challenges Of Today’s Pharmaceutical Industry”, Malta 2008.

The Qualified Person and Minor Deviations
Piero Iamartino, EIPG Vice-President
Presentation at Malta Qualified Persons Association-European Industrial Pharmacists Group-University of Malta joint seminar “The Successes And Challenges Of Today’s Pharmaceutical Industry”, Malta 2008.

Quality Charter and Certification For Medical Representatives In France
Jean-Pierre Paccioni, EIPG Treasurer, and Françoise Robinet, EIPG French Delegate
Presentation at Malta Qualified Persons Association-European Industrial Pharmacists Group-University of Malta joint seminar “The Successes And Challenges Of Today’s Pharmaceutical Industry”, Malta 2008.

Pricing of Medicinal Products and Reimbursement Systems in Europe
Kiriasis Savvas, EIPG Greek Delegate
Presentation at Malta Qualified Persons Association-European Industrial Pharmacists Group-University of Malta joint seminar “The Successes And Challenges Of Today’s Pharmaceutical Industry”, Malta 2008.

Industry Implications Of Pharmaceutical Quality ICH Guidelines
John Jolley, EIPG UK Delegate
Presentation at the EIPG General Assembly, Malta 2008.

Powerpoint presentations are available in Powerpoint format against a donation of Euro 25 to the EIPG. Please contact EIPG for further information